GB1467503A - Process for the production of attenuated feline panleukopenia virus and vaccine - Google Patents

Process for the production of attenuated feline panleukopenia virus and vaccine

Info

Publication number
GB1467503A
GB1467503A GB2268274A GB2268274A GB1467503A GB 1467503 A GB1467503 A GB 1467503A GB 2268274 A GB2268274 A GB 2268274A GB 2268274 A GB2268274 A GB 2268274A GB 1467503 A GB1467503 A GB 1467503A
Authority
GB
United Kingdom
Prior art keywords
vaccine
virus
attenuated
production
tissue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB2268274A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rohm and Haas Co
Original Assignee
Rohm and Haas Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rohm and Haas Co filed Critical Rohm and Haas Co
Publication of GB1467503A publication Critical patent/GB1467503A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14311—Parvovirus, e.g. minute virus of mice
    • C12N2750/14322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

1467503 Attenuated feline panleukopenia virus and vaccine ROHM & HAAS CO 21 May 1974 [4 June 1973] 22682/74 Heading A5B A process for the production of an attenuated feline panleukopenia (FPL) virus, or an attenuated FPL vaccine, comprises serially attenuating, and in the case of a vaccine, subsequently propagating, a FPL virus, wherein, in at least one of the serial attenuation steps, and/or the propagation step in a vaccine production process, the virus, or the attenuated virus in the case of a propagation step, is cultured in a liquid culture medium containing ferret (Mustela) tissue cells in suspension. Preferably in the production of the vaccine the virus is first attenuated on a suspension of ferret tissue, and then subjected to passage through feline tissue before propagation on a suspension of ferret tissue.
GB2268274A 1973-06-04 1974-05-21 Process for the production of attenuated feline panleukopenia virus and vaccine Expired GB1467503A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US367032A US3892627A (en) 1973-06-04 1973-06-04 Feline panleukopenia vaccine

Publications (1)

Publication Number Publication Date
GB1467503A true GB1467503A (en) 1977-03-16

Family

ID=23445653

Family Applications (1)

Application Number Title Priority Date Filing Date
GB2268274A Expired GB1467503A (en) 1973-06-04 1974-05-21 Process for the production of attenuated feline panleukopenia virus and vaccine

Country Status (6)

Country Link
US (1) US3892627A (en)
BE (1) BE815871A (en)
DE (1) DE2425997A1 (en)
FR (1) FR2231368B1 (en)
GB (1) GB1467503A (en)
NL (1) NL7407234A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112877297A (en) * 2021-03-27 2021-06-01 哈尔滨元亨生物药业有限公司 Method for preparing cat distemper virus monoclonal antibody by using bioreactor

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4287178A (en) * 1974-03-25 1981-09-01 Pitman-Moore, Inc. Feline rhinotracheitis vaccine and production and use thereof
DE2602478C3 (en) * 1976-01-23 1980-10-09 Behringwerke Ag, 3550 Marburg Felida panleucopenia vaccine
EP0011864B1 (en) * 1978-11-30 1982-05-19 The Wellcome Foundation Limited Attenuated strain of feline infectious peritonitis virus, method for preparing it and vaccine comprising it
US4193990A (en) * 1979-02-16 1980-03-18 Cornell Research Foundation, Inc. Heterotypic canine parvovirus vaccine
US4303644A (en) * 1979-10-16 1981-12-01 Norden Laboratories, Inc. Feline infectious peritonitis virus vaccines
US4303645A (en) * 1980-04-18 1981-12-01 Cornell Research Foundation, Inc. Modified living canine parvovirus vaccine
US4711778A (en) * 1980-07-30 1987-12-08 Norden Laboratories, Inc. Inactivated rabies vaccine for veterinary use
US4572834A (en) * 1984-04-10 1986-02-25 Clinical Reference Laboratory, Inc. Biologic and method of preparing same
CN103773739B (en) * 2013-03-01 2016-06-15 上海启盛生物科技有限公司 A kind of feline panleukopenia virus attenuated vaccine strain and application thereof
WO2017106079A1 (en) 2015-12-14 2017-06-22 Boehringer Ingelheim Vetmedica, Inc. Hybrid core feline vaccines

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL300960A (en) * 1962-11-27
GB1177635A (en) * 1966-02-18 1970-01-14 Wellcome Found Cell Stains.
US3562387A (en) * 1967-12-01 1971-02-09 Mogul Corp Mink virus enteritis vaccine and method for the production thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112877297A (en) * 2021-03-27 2021-06-01 哈尔滨元亨生物药业有限公司 Method for preparing cat distemper virus monoclonal antibody by using bioreactor

Also Published As

Publication number Publication date
DE2425997A1 (en) 1975-01-02
US3892627A (en) 1975-07-01
FR2231368B1 (en) 1977-11-04
FR2231368A1 (en) 1974-12-27
NL7407234A (en) 1974-12-06
BE815871A (en) 1974-12-04

Similar Documents

Publication Publication Date Title
GB1467503A (en) Process for the production of attenuated feline panleukopenia virus and vaccine
DK163932C (en) Process for producing a mammalian protein heterologous to a yeast organism as a product of yeast expression processing and secretion as well as yeast organism cell culture, cell culture culture medium and yeast expression medium
IL61505A (en) System for producing accelerated migration of algal cells and process and apparatus for harvesting therefor
JPS5381681A (en) Bio-reaction process
IE46215L (en) Gamma-globulins, immune nucleic acids and immune dialysates.
ATE46358T1 (en) PROCESS FOR CULTIVATION OF LYOPHILIZED MICROORGANISMS.
JPS52129788A (en) Process for preparing porous cellulose beads
GB1263765A (en) A method for the production of protease by cultivating bacteria
DK0749489T3 (en) Expression cassette comprising a promoter derived from the pho4 gene of Schizosaccharomyces pombe
ATE28214T1 (en) MALOLACTIC FERMENTATION PROCESS.
US2424832A (en) Process for producing penicillin
EP0095268A3 (en) Improved mycostatic whey and process of manufacture
EP0112154A3 (en) Method for culturing living cells
GB1104197A (en) Method of producing uricase from yeast
GB1158387A (en) Procedure for Isolation of Mycophenolic Acid
ES346459A1 (en) Process for producing proteins by fermentation
EP0146378A3 (en) Fermentation process for the preparation of aconitic acid
GB1303560A (en)
PT83368A (en) Process for propagating microorganisms in vivo by using cell lines which lack human class ii histocompatibility antigens
GB1185012A (en) Improvements in or relating to Photographic Gelatin
GB1288843A (en)
GB1503851A (en) Process for preparing cephalosporin
SU420153A3 (en) METHOD OF ISOLATION AND / OR CLEANING OF CEFAMICINE C
ATE12646T1 (en) AM-5344-A2 ANTIBIOTIC AND METHOD OF PRODUCTION.
SU150808A1 (en) Method for determining activity of cytolytic enzymes

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
732 Registration of transactions, instruments or events in the register (sect. 32/1977)
PCNP Patent ceased through non-payment of renewal fee